GPX4 and mitochondrial disease: Accordingly, targeting either 15-LO with the intent to decrease the formation of lipid peroxides or GPX4 to increase the catalytic clearance of lipid hydroperoxides represent rational therapeutic approaches to modulate ferroptosis as an intervention for mitochondrial disease-associated epilepsy.